stockrow
Friday 6 November 2026
Export IRON’s income statement to Excel — free account
Disc Medicine, Inc.
IRON Healthcare Biotechnology
- EPS
- +2.53%
- Free cash flow
- +7.83%
- Total debt
- +106.5%
Quarter to June 2026, against a year earlier
78.51
0.04
+0.05%
Follow IRON
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
23.45 | 21.94 | 24.00 | 24.14 |
Net Debt/EBITDA |
8.46 | 11.12 | 9.94 | 10.06 | |
Debt/Assets |
4.59% | 3.61% | 3.91% | 8.07% | |
Debt/Equity |
0.05 | 0.04 | 0.04 | 0.09 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.77 | 0.72 | 0.98 | 0.74 | |
Capex/Depreciation |
0.02 | 0.01 | 0.00 | 0.00 | |
Interest Coverage |
(73.82) | (75.84) | (82.37) | (71.67) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.36) | (1.23) | (1.62) | (1.14) | |
Cash per Share |
17.51 | 22.42 | 18.97 | 18.55 | |
Shareholders Equity per Share |
16.30 | 20.96 | 17.89 | 16.65 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.30 | 20.96 | 17.89 | 16.65 | |
Free Cash Flow |
(47.82) | (43.32) | (62.24) | (44.20) | |
Working Capital |
600.42 | 767.26 | 716.31 | 702.40 | |
Capital Expenditures |
(0.03) | (0.02) | — | — | |
Net Current Asset Value |
570.10 | 736.85 | 685.67 | 641.85 | |
| Other line items | |||||
Quick Ratio |
23.03 | 21.59 | 23.45 | 23.64 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.36) | (1.23) | (1.62) | (1.14) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
5.41 | 8.48 | 9.23 | 6.60 | |
Average Assets |
562.80 | 651.83 | 729.74 | 700.07 | |
Average Common Equity |
520.68 | 591.71 | 674.40 | 629.16 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates